RFA | CBA | |||||
---|---|---|---|---|---|---|
HR | 95%CI | p value | HR | 95%CI | p value | |
Univariate analysis | ||||||
Age | 0.998 | 0.965–1.032 | 0.909 | 1.045 | 0.990–1.102 | 0.108 |
BMI | 0.931 | 0.853–1.016 | 0.107 | 1.224 | 1.057–1.418 | 0.007 |
AF duration | 1.055 | 1.000–1.113 | 0.052 | 1.021 | 0.967–1.078 | 0.452 |
Gender, female | 0.943 | 0.464–1.918 | 0.872 | 0.680 | 0.232–1.992 | 0.482 |
Hypertension | 0.675 | 0.341–1.333 | 0.257 | 1.211 | 0.544–2.698 | 0.640 |
Diabetes | 0.868 | 0.361–2.087 | 0.751 | 0.960 | 0.284–3.240 | 0.947 |
Coronary heart disease | 2.248 | 0.984–5.136 | 0.055 | 1.330 | 0.397–4.461 | 0.644 |
Heart failure | 2.375 | 0.564–9.992 | 0.238 | 2.328 | 0.544–9.964 | 0.255 |
Stroke/TIA | 0.381 | 0.052–2.782 | 0.341 | 1.528 | 0.454–5.142 | 0.494 |
LA diameter | 1.108 | 1.025–1.198 | 0.010 | 1.011 | 0.911–1.122 | 0.835 |
LVEF | 0.991 | 0.953–1.029 | 0.631 | 0.981 | 0.919–1.046 | 0.551 |
CHA2DS2-VASc score | 0.992 | 0.775–1.270 | 0.951 | 1.132 | 0.770–1.662 | 0.528 |
Additional ablation | 1.234 | 0.377–4.034 | 0.728 | – | – | – |
CRP 24 h | 1.009 | 0.985–1.033 | 0.477 | 0.994 | 0.952–1.037 | 0.765 |
CRP 48 h | 1.001 | 0.984–1.017 | 0.941 | 1.019 | 0.983–1.056 | 0.303 |
AER | 1.915 | 0.838–4.376 | 0.124 | 2.481 | 0.846–7.278 | 0.098 |
NAER | 4.745 | 2.332–9.655 | < 0.001 | 5.660 | 2.453–13.059 | < 0.001 |
Multivariate analysis | ||||||
Age | 0.831 | 0.704 | ||||
BMI | 0.062 | 0.459 | ||||
AF duration | 0.054 | 0.330 | ||||
Coronary heart disease | 0.268 | 0.124 | ||||
LA diameter | 1.103 | 1.020–1.193 | 0.015 | 0.913 | ||
AER | 0.055 | 3.169 | 1.037–9.687 | 0.043 | ||
NAER | 4.610 | 2.243–9.476 | < 0.001 | 6.760 | 2.845–16.06 | < 0.001 |